Top

States Try to Obscure Execution Details as Drugmakers Hinder Lethal Injection

Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

Almond, Soy Drinks Can Be Called Milk, FDA Proposes

GSK and Vir Biotech amend COVID-19 research partnership

Tag: atopic dermatitis

Biotech, Clinical Trials, Industry, Research and Development

Vanda Pharmaceuticals shares in the red as skin disease test fails

February 26, 2020

Via: FierceBiotech

Vanda Pharmaceuticals is hoping to try again with an amended trial after its experimental skin drug tradipitant failed a phase 3 test. The drug was being assessed to see whether it could help pruritus (itching) in patients with in atopic […]